Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Advancements in Targeted Therapies for Vitiligo: Prioritizing Equity in Drug Development.
Bioterrorism
CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells.
Gene therapy in metachromatic leukodystrophy.
Human Binge Alcohol Intake Inhibits TLR4-MyD88 and TLR4-TRIF Responses but Not the TLR3-TRIF Pathway: HspA1A and PP1 Play Selective Regulatory Roles.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Advancements in Targeted Therapies for Vitiligo: Prioritizing Equity in Drug Development.
Delva C, Pearson TF, Harris JE. Advancements in Targeted Therapies for Vitiligo: Prioritizing Equity in Drug Development. Cutis. 2024 Apr; 113(4):156-158.
View in:
PubMed
subject areas
Dermatologic Agents
Humans
Molecular Targeted Therapy
Vitiligo
authors with profiles
John E Harris MD, PhD
Todd F Pearson PhD